Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | SPB | CL |
|---|---|---|
| Price | $75.99 | $86.19 |
| Change today | ▼ 2.98% | ▲ 2.29% |
| Market cap | $1.75B | $68.71B |
| Return, 3 months | -8.4% | -8.8% |
| Return, year to date | +30.9% | +11.1% |
| Return, 1 year | +47.2% | +14.1% |
| P/E (TTM) | 23.8 | 33.9 |
| P/B | 0.9 | 291.2 |
| P/E percentile vs own 5y | 71st | 70th |
| Dividend yield | 2.47% | 2.42% |
| Revenue growth (YoY, latest qtr) | +7.7% | +4.9% |
| Net profit growth (YoY) | -209.1% | -7.0% |
| Gross margin | 49.2% | 60.4% |
| Operating margin | 16.8% | 19.3% |
| Net margin | -2.9% | 9.7% |
| Return on equity | – | 434.5% |
| Analyst target vs. price | +27.1% | +19.0% |
| Analyst buy share | 40% | 89% |
| RSI (14) | 24 | 45 |
| 30-day volatility | 25.6% | 15.6% |
| Max drawdown, 1 year | -16.0% | -17.0% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
